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The whole amino acid sequence of nidogen was deduced
from cDNA clones isolated from expression libraries and
confirmed to - 50% by Edman degradation of peptides.
The protein consists of some 1217 amino acid residues
and a 28-residue signal peptide. The data support a
previously proposed dumb-bell model of nidogen by
demonstrating a large N-terminal globular domain (641
residues), five EGF-like repeats constituting the rod-like
domain (248 residues) and a smaller C-terminal globule
(328 residues). Two more EGF-like repeats interrupt the
N-terminal and terminate the C-terminal sequences.
Weak sequence homologies (25%) were detected between
some regions of nidogen, the LDL receptor, thyroglobulin
and the EGF precursor. Nidogen contains two consensus
sequences for tyrosine sulfation and for asparagine 3-
hydroxylation, two N-linked carbohydrate acceptor sites
and, within one of the EGF-like repeats an Arg-Gly-
Asp sequence. The latter was shown to be functional in
cell attachment to nidogen. Binding sites for laminiin and
collagen IV are present on the C-terminal globule but
not yet precisely localized.
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Introduction
Nidogen is one of the ubiquitous proteins in basement
membranes, extracellular matrices in close molecular and
functional contact to a large variety of cells. It is known that
these contacts are mainly mediated by laminin and collagen
IV, two large proteins which are highly integrated in the
matrix architecture (reviewed by Kleinman et al., 1985;
Timpl and Dziadek, 1986; Martin and Timpl, 1987).
Nidogen is often found in close association with laminin
(Dziadek and Timpl, 1985; Dziadek et al., 1985a; Paulsson
et al., 1987) but its precise biological function remains to
be identified.
After isolation from the matrix of the Engelbreth-
Holm -Swarm (EHS) tumor, nidogen was shown to consist
of a single 148 kd polypeptide chain. This chain is folded
into two globular domains of unequal size which are
connected by a 17 nm long rod-like domain (Paulsson et al.,
©IRL Press
1986, 1987). The protein is very susceptible to degradation
by endogenous proteases with cleavages occurring at both
ends of the chain as demonstrated by limited sequence
analysis (Dziadek et al., 1985b; Paulsson et al., 1986; Mann
et al., 1988). A related protein, entactin, was originally
identified as a sulfated 158 kd polypeptide (Carlin et al.,
1981) and shown to contain tyrosine sulfate (Paulsson et al.,
1985). Entactin also binds to laminin (Hogan et al., 1982;
Carlin et al., 1983) and was recently characterized by a
partial cDNA sequence (Durkin et al., 1987). This deduced
amino acid sequence contained some short segments related
to nidogen but in different positions on the protein (Mann
et al., 1988) leaving the relationship between the two proteins
still an open question.
The laminin-binding site of nidogen was recently localized
to its C-terminal globular domain (Mann et al., 1988). In
addition, we found that the same domain binds to triple
helical segments of collagen IV (M.Aumailley et al., in
preparation) suggesting a mediator function for nidogen in
basement membranes. In order to allow a better under-
standing of the structure - function relationships we have now
determined the whole primary structure of mouse nidogen
by cDNA and peptide sequencing. The data reveal a single
Arg -Gly -Asp (RGD) sequence within one of several
cysteine-rich motifs with similarity to epidermal growth
factor (EGF). That this putative cell-binding sequence
(Ruoslahti, 1988) in fact mediates cell-binding to nidogen
was shown in additional experiments.
Results
Cloning of cDNA encoding nidogen
Screening of two different Xgtl 1 expression libraries made
from mouse EHS tumor mRNA by antibodies against mouse
nidogen allowed the isolation of four overlapping clones (6c,
21b, 37a, 40a) with a size of 0.5-1.5 kb. They were all
located upstream to an internal EcoRI site present within the
nucleotide sequence encoding nidogen (Figure 1). Two other
clones that contained sequences downstream from this EcoRI
site were obtained from a third EHS tumor library con-
structed in the XZAP vector. These two clones, N-2 and N-3,
started - 1000 and 400 nt, respectively, to the 5' end of this
EcoRI site, both extended over this site to another EcoRI
site 240 nt to the 3' end, and then both terminated with a
short poly(A) tail (- 15 nt) -400 nt further downstream.
In addition, a 3.6 kb clone N-5 was isolated from a mouse
F9 cell library. This clone ended at the first internal EcoRl
site and extended close to the 5' end of nidogen mRNA.
A restriction map of these clones is shown in Figure 1.
Northern hybridization of the nidogen probe 6c to mouse
tumor RNA demonstrated a major band of - 6 kb and a
weaker reacting band of - 4 kb (Figure 2B). The same probe
also hybridized to a similar 6 kb band in human mRNA
under stringent conditions (Figure 2A), indicating a distinct
sequence similarity of mouse and human nidogen.
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Fig. 1. Alignment and restriction maps of cDNA clones encoding
mouse nidogen. Clones were purified from either Xgtl 1 EHS tumor
libraries (6c, 37a, 21b, 40a) after antibody screening or from an EHS
tumor library in the XZAP vector (N-2, N-3) or a Xgtl 1 F-9 cell
library (N-5) after screening with 6c probe. B: BamHI, E: EcoRI, P:
PstI. A denotes a poly(A) tail.
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Fig. 2. Northern hybridization of mouse nidogen cDNA probe 6c to
RNA from EHS tumor or human hepatoma cell line G2. Lanes were
loaded with either total RNA from EHS tumor (20 ,tg, lane B) or
with poly(A)+ RNA from hepatoma (1.8 Ag, lane A). Band sizes are
indicated in kb.
Amino acid sequence of nidogen deduced from cDNA
clones
The various cDNA clones were used to determine most of
the sequence of nidogen mRNA including the entire coding
region. First, the 1.5 kb clone 6c was analyzed by the shot
gun strategy in both directions and the sequence was
extended to the 3' and 5' ends using clones N-2, N-3 and
N-5 as described in Material and methods.
The analyzed cDNA sequence (4185 nt) and the deduced
amino acid sequence are shown in Figure 3. Some 106 nt
downstream from the 5' end the sequence encodes the
sequence LNRQELFPFG which was obtained previously at
the protein level as the N-terminal sequence of nidogen
(Dziadek et al., 1985b; Paulsson et al., 1986). This indicates
that a Cys - Leu bond is the site of cleavage of the signal
peptide. An open reading frame (ORF) extending 3651 nt
to the first stop codon TGA at the 3' end demonstrated that
mouse nidogen consists of 1217 amino acid residues. This
sequence contains 48 cysteine residues, many of them located
within EGF-like repeats, a single RGD sequence possibly
involved in cell-binding and two putative N-linked carbo-
hydrate acceptor sequences. The nidogen sequence is
preceded by a typical signal peptide (von Heijne, 1986) of
either 18 or 28 amino acid residues. Ambiguity on the size
of the signal peptides arises from two in-frame Met codons
in nucleotide positions 22 and 52. A purine base is present
3 nt upstream from both ATG codons which is the most
conserved feature for initiation of translation in vertebrates
(Kozak, 1987). The sequence is terminated at the 3' end by
a 415 nt non-coding region and a poly(A) tail. This sequence
contains several stop codons in all three reading frames.
Peptide chemistry
About 50% of the deduced nidogen sequence was confirmed
by Edman degradation of larger fragments and small tryptic
peptides (Figure 3). Particular attention was given to the rod-
like domain and the C-terminal globular domain because of
their possible involvement in biological activities (discussed
below). The rod-like domain was isolated as tryptic fragment
T-40 (Mann et al., 1988), cleaved after reduction and
alkylation with SV8 protease and the peptides obtained were
resolved by reversed-phase chromatography (Figure 4). Most
of the peaks were sequenced and fitted exclusively positions
631 -874 of the nidogen sequence. The C-terminal 22 kd
thrombin fragment Th-22 (Mann et al., 1988) was reduced
and cleaved with trypsin and produced a less complex profile
of peptides. All prominent peaks were sequenced and
accounted for - 80% of the sequence deduced for the last
180 C-terminal amino acid residues. No peptide sequences
were found beyond the predicted stop codon.
Peptide sequences for the N-terminal half of nidogen were
generated in a similar way from the N-terminal thrombin
fragment Th-50 (Mann et al., 1988) and the endogenous
fragment Nd-100 (Paulsson et al., 1986) which were
subjected to trypsin or elastase cleavage and HPLC separ-
ation omitting the reduction of disulfide bonds (data not
shown). This allowed the generation of 14 separate peptide
sequences matching N-terminal positions within nidogen. In
addition, we found the N-terminal sequences determined
previously (Dziadek et al., 1985b; Paulsson et al., 1986;
Mann et al., 1988) for endogenous nidogen fragments
Nd-130, Nd-100, Nd-80 and Nd40 and some thrombin
fragments (Figure 3).
Cell-binding to nidogen mediated by an RGD
sequence
The observation of a single RGD sequence (Figure 3)
prompted us to examine cell-binding properties of nidogen
by cell adhesion assays (Aumailley and Timpl, 1986;
Aumailley et al., 1987). Studies with osteosarcoma cell line
SAOS-2 showed a typical dose-response profile with a
plateau region of attachment achieved at low concentrations
of nidogen (Figure 5). Similar adhesion profiles were
observed with human skin fibroblasts and SV-40 transformed
lung fibroblasts. Cell attachment and spreading on nidogen
required, however, 2-3 h when compared to the more
active laninin -nidogen complex (30 min) which also caused
higher attachment rates (Figure 5). The higher activity of
the complex is presumably due to a high affinity binding
site present on the long arm of laminin which dominates
cellular interactions (Aumailley et al., 1987).
A more precise localization of the cell-binding site was
achieved by using nidogen fragment Nd-80 (Paulsson et al.,
1986) in attachment assays which showed an activity similar
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Fig. 3. Nucleotide and amino acid sequence of mouse nidogen. The nucleotide sequence was determined from cDNA clones shown in Figure 1.
Underlined amino acid sequences were confinmed by Edman degradation of peptides isolated from various nidogen domains. Cysteine residues are
encircled and potential N-linked carbohydrate acceptor sites and a RGD cell-binding site are shown in boxes. Open arrow heads mark the N-termini
of endiorenouse nidogen fragments Nd-130 (p)osition 204), Nd-100 (position 298), Nd-80 (position 351) and Nd-40 (position 621) described in previous
studies (Dziadek et al., 1985b; Paulsson et al., 1986) and of the thrombin fragments Th-100 (position 301) and Th-22 (position 1038) (Mann et al.,
1988). A potential polyadenylation signal is underlined. Differences between the deduced amino acid sequence and results of Edman degradation
(given in brackets) were noted for positions 140 (G), 143 (V), 146 (A) and 631 (R). They are all explained by single base substitutions.
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Fig. 4. HPLC profiles of tryptic peptides obtained from the rod-like domain (T-40/SV8) and a portion of the C-terminal globular domain (Th-22/T)
of nidogen. The numbered peaks contained peptides identified by Edman degradation. Peptides in the upper panel were additionally cleaved with SV8
protease prior to separation.
to those of intact nidogen (Figure 5). This fragment
corresponds to the rod-like domain and portions of the N-
terminal globule of nidogen. Cell attachment to nidogen could
also be inhibited by synthetic peptides. It was reduced to
a 20% level by low concentrations of GRGDS (10 I4g/ml)
while related peptides RGES and AGDV required more than
a 10- to 50-fold higher concentration to obtain the same
effect.
Discussion
The cDNA clones described here allowed us to determine
the entire coding sequence of mouse nidogen mRNA with
an ORF of 3735 nt which encode some 1217 amino acid
residues of nidogen and a typical 28-residue signal peptide.
Edman degradation of nidogen peptides was used to identify
the N- and C-terminal ends of the protein and to confirm
- 50% of the deduced amino acid sequence. The 28 amino
acid residues predicted to precede the N-terminus show the
characteristic features of a signal peptide (von Heijne, 1986).
Whether the signal peptide in fact starts at a second Met at
position -18 remains open. According to the scanning model
of eukaryotic ribosome initiation (Kozak, 1984), the first
ATG codon is more likely to be used as an initiator. In
addition, it is in a better context for initiation than the second
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Fig. 5. Cell attachment of osteosarcoma cells SAOS-2 to nidogen.
Substrates used were the laminin-nidogen complex (0), nidogen (A)
and the nidogen fragment Nd-80 (O). Attached cells were quantifiedby a colorimetric assay.
ATG (Kozak, 1987) and the second ATG is not conserved
in the human nidogen sequence (our unpublished observa-
tion).
Two mouse mRNA transcripts were recognized by the
nidogen cDNA probe, a major one of 6 kb and a minor one
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of 4 kb. These two mRNAs may differ in the coding or non-
coding region. Several observations seem to favor the latter
possibility. The ORF identified in the overlapping cDNA
clones is of sufficient size to encode the entire nidogen
sequence (see below). In addition, the 3' untranslated region
is terminated by a short poly(A) tail preceded by a variant
of the consensus polyadenylation signal (AATAAA versus
AAATAA; see Swimmer and Shenk, 1985) in two indepen-
dent clones (N-2 and N-3). This suggests that these two
clones are derived from the shorter mRNA species. Whether
the longer mRNA species contains additional sequences only
in the 3' untranslated region remains to be determined.
The amino acid sequence of nidogen together with - 5%
carbohydrate predicts a mol. wt of 141 kd which is in good
agreement with a value of 148 kd determined by ultra-
centrifugation (Paulsson et al., 1986). Furthermore, all the
peptide sequences determined here and in previous studies
were found in the coding region of the cDNA clones. The
data also agree well with the dumb-bell model of nidogen
proposed from electron microscopical observations (Paulsson
et al., 1986, 1987). They show that the 641 residue long
N-terminal sequence forms the large globular domain I,
followed by 248 residues in cysteine-rich repeats contributing
the rod-like structure (domain II) and a smaller (328 residues)
C-terminal globular domain III (Figure 6). Amino-terminal
sequences described for nidogen and fragments produced by
endogenous proteases during its extraction (Dziadek et al.,
1985b; Paulsson et al., 1986) were all found in the N-
terminal domain I with that of fragment Nd-40 being in front
of domain II. This confirms predictions on the localization
of these fragments based on electron microscopical and
immunological studies (Mann et al., 1988; Paulsson et al.,
1986). It also suggests that the bonds readily cleaved by
endogenous proteases (Dziadek et al., 1985a) are located
in flexible segments of the N-terminal globule giving rise
to three globular subdomains Ia, b and d and one EGF-like
repeat Ic (Figure 6). Three subdomains can also be
distinguished in the C-terminal globule, namely a hydro-
phobic and proline-rich segment IHa close to the rod
(positions 890-956), a globular structure IIIb with two
putative disulfide bonds in the center followed by an EGF-
like repeat IIIc directly at the C-terminus.
The rod-like domain of nidogen is composed of five
consecutive EGF-like repeats (numbered Ila-IIe) which
show internal homology in the positions of the six cysteines
and several other residues (Figure 7) suggesting that they
may have evolved by exon duplication. These segments
apparently serve a structural purpose by separating the
globular domains of nidogen by a 17 nm long, flexible link
(Paulsson et al., 1987) similarly to analogous repeats found
in the rod-like portions of the short arms of laminin B1 and
B2 chains (Sasaki et al., 1987; Sasaki and Yamada, 1987).
However, the latter structures are characterized by an eight
rather than six cysteine residue repeat. In addition, such
EGF-like repeats could express biological functions as
indicated by a putative RGD cell-binding sequence being
present between Cys-5 and Cys-6 of nidogen domain Ila
(Figures 3 and 7). EGF-like repeats have been found in quite
a few proteins and are commonly divided based on
homologies into three different classes (Appella et al., 1988).
The EGF-like repeats of nidogen are similar to those in
classes 11 or HI which also include the EGF precursor, LDL
receptor and several coagulation proteins. A particularly
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Fig. 6. Correlation between the amino acid sequence and domain
structure of nidogen. The model of three major domains (I-HI) is
based on electron microscopy and ultracentrifugation (Paulsson et al.,
1986, 1987) and related to the sequence. Vertical black bars denote
the start of various large nidogen fragments (Nd-130, Nd-100, Nd-80,
Nd-40) which arise by endogenous proteolysis (Paulsson et al., 1986),
suggesting several subdomains within the large N-terminal globule (I).
These and other subdomains are denoted by small letters. Five EGF-
like repeats constitute the rod with a further repeat being present
within domain I and at the C-terminus. Th denotes major sites of
thrombin cleavage. Full arrows indicate positions of two potential
tyrosine sulfate acceptor sites and of a single RGD sequence with the
potential for cell-binding. SS denotes pairs of cysteine residues (besides
those in the EGF-like repeats) possibly involved in intradomain
disulfide bridges.
striking identity (50%) is observed between an EGF repeat
of thyroglobulin (Malthiery and Lissitzky, 1987) and nidogen
domain He which has unusually long inserts between Cys-1
and 2 and Cys-5 and 6 (Figure 7). The EGF-like repeat
Ic is also atypical containing seven instead of six cysteines
(Figure 7) which suggests one free thiol group or binding
to the single cysteine (position 588) in domain Id. Odd
numbers of cysteines in such repeats are rather uncommon
but were found in the ,3 subunit of the fibronectin receptor
(Argraves et al., 1987).
Another homology with - 25% identical residues is found
between nidogen domain HI (positions 890-1209), EGF
precursor (positions 487-775; Scott et al., 1983) and LDL
receptor (positions 372-703; Yamamoto et al., 1983).
However, this only becomes apparent by introducing several
gaps and does not match the cysteine residues of subdomain
11Ib (not shown). It remains therefore doubtful whether this
similarity indicates any structural or functional relationship.
Our sequence data also shed some light on the possible
identity of nidogen (Paulsson et al., 1985) and entactin
(Carlin et al., 1981, 1983). The amino acid sequence
deduced from a 1.3 kb entactin cDNA clone (Durkin et al.,
1987) corresponds with a few exceptions to the nidogen
sequence position 63-385 but is followed by 0.35 kb of
a completely different sequence. Since the segment at
variance is supported by three nidogen peptide sequences
(starting at positions 385, 439 and 489, respectively, see
Figure 3) it indicates that the entactin clone is a rearranged
product. It nevertheless also indicates that nidogen and
entactin are identical.
The nidogen sequence contains two Tyr residues (positions
262 and 267) in the sequence DDDGADYEDEDYD, which
due to the acidic neighbouring residues represent typical
acceptor sites for O-sulfation (Huttner and Baiuerle, 1988).
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Fig. 7. Comparison of seven EGF-like repeats of nidogen with regions of high homology shown in boxes. Numbering of cysteines on top follows
those for EGF. Sequences shown correspond to positions 360-399 (Ic), 1182-1217 (IlIc) and 642-900 (IIa-e) in Figure 3. Two Asn residues
within consensus sequences for f-hydroxylation (Rees et al., 1988) are indicated by an asterisk. An RGD sequence is marked by a double line.
This is of some interest since entactin was originally
identified by sulfate labeling (Carlin et al., 1981; Hogan
et al., 1982). Other studies with nidogen showed the label
to be present on tyrosine possibly involving two residues
in the N-terminal thrombin fragment Th-50 (Paulsson et al.,
1985; and unpublished). This is in good agreement with the
sequence data and allows a precise identification of the sulfate
acceptor sites. Nidogen also possesses two NXT/NXS sites
(positions 159 and 387; Figure 3), putative acceptors for N-
linked oligosaccharides. With a 2.0% glucosamine content
(Paulsson et al., 1986) it indicates that all acceptor sites are
occupied by complex types of oligosaccharide side chains
and is in agreement with the failure to identify Asn residue
387 by Edman degradation. About 0.9% galactosamine in
nidogen also suggests the presence of six or seven 0-linked
oligosaccharides which have not been assigned so far to
specific sequence positions.
A further post-translational modification of nidogen may
include the 3-hydroxylation of two Asn residues present in
the EGF-like repeats IIb and Ild (Figure 7). Hydroxylated
Asn or Asp residues are often found in EGF-like domains
of various calcium-binding proteins (i.e. coagulation factors,
complement components) and are surrounded at some
variable distance by the consensus sequences DXDXC and
FXC (Rees et al., 1988). These consensus sequences are
also present in nidogen (Figure 7) and small amounts of 3-
hydroxyaspartate have been recently detected in nidogen
hydrolysates (S.Stenflo, personal communication). This
suggests that nidogen is also a calcium-binding protein as
found recently for other basement membrane components
such as laminin (Paulsson, 1988) and BM-40 (Engel et al.,
1987).
The identification of an RGD sequence within the EGF-
like repeat H1a provided the first strong indication that nidogen
like laminin (Kleinman et al., 1985; Martin and Timpl, 1987)
and collagen IV (Aumailley and Timpl, 1986) could belong
to the potential cell-binding basement membrane proteins.
This was confirmed in cell attachment studies, as a major
binding site was located to domains Ic and Id plus II of
nidogen (fragment Nd-80). Cell binding was also inhibited
by synthetic RGD peptides while control peptides differing
at the Arg or Asp position were less active There are
permutations of the RGD motif including DRG, DGR and
RDG in other EGF-like repeats in nidogen (Figure 7). This
is of some interest since the inverted cell-binding sequences
DGR has been shown to interfere with cell-binding to laminin
and fibronectin (Yamada and Kennedy, 1987). The evalu-
ation of the biological importance of these sequences will
require cell-binding studies with various relevant synthetic
peptides from nidogen domain II. Our observations also
suggest that nidogen binds to cellular receptors of the integrin
family (Hynes, 1987; Ruoslahti, 1988). RGD-dependent
integrin binding has for example been shown for fibronectin
(Pytela et al., 1985), vitronectin (Pytela et al., 1986) and
collagen I (Dedhar et al., 1987). Whether nidogen can bind
to one or all of these receptors or requires a specific integrin
receptor remains to be determined.
Nidogen binds strongly to laminin via its C-terminal
domain (Paulsson et al., 1987; Mann et al., 1988). Laminin
is also known to possess two high affinity cell-binding sites
(Aumailley et al., 1987; Goodman et al., 1987). Since
laminin and nidogen seem to be complexed in a variety of
tissues (Dziadek and Timpl, 1985), this interaction should
increase the potential for cellular recognition within a narrow
topological array. The C-terminal domain Ill of nidogen also
has the potential to bind to two different sites in the triple
helical domain of collagen IV although with apparently lower
affinity compared to the binding of laminin (M.Aumailley
et al., in preparation). The precise identification of the
binding sequences of nidogen for laminin and collagen IV
seems feasible based on the information provided here and
may then be exploited in further functional studies. This
should assist in a better understanding of the obviously com-
plex role played by nidogen in basement membranes.
Materials and methods
Isolation of nidogen peptides and amino acid sequencing
Large fragments of nidogen used for sequence analysis included the
endogenous fragment Nd-100, the thrombin fragments Th-100, Th-50 and
Th-22 and the tryptic fragment T-40 (Paulsson et al., 1986; Mann et al.,
1988). They were cleaved either prior to or after reduction of disulfide bonds
with TPCK-trypsin (Mann et al., 1988). Fragment T40 which was released
from Nd-100 prior to reduction was reduced and alkylated in 6 M
guanidine-HCI (Paulsson et al., 1986) and subjected to a second digestion
by SV8 protease (enzyme-substrate ratio 1: 50, 8 h at 200C). The various
peptide mixtures were separated on a reversed phase column (RP 318,
C 18-coated, BioRad Laboratories, Munich) which was equilibrated in 0.1 %
trifluoroacetic acid and eluted with a gradient of acetonitrile (Chu et al.,
1987). Digests of non-reduced Nd-I00 and Th-100 were initially separated
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into large and smaller fragments by chromatography on a Sephadex G-150
column equilibrated in 0.2 M ammonium bicarbonate.
Edman degradations were performed with 0.01-1 nmol peptide samples
on a gas phase sequencer or a spinning-cup liquid-phase sequencer as
previously described (Chu et al., 1987; Hartl et al., 1988). Amino acid
sequences were screened for internal repeats and homologies to other proteins
by the programs FASTP (Lipman and Pearson, 1985) DOTMATRIX (PSQ),
SEQHP and SEQDP.
Isolation of cDNA clones and Northern blots
Total RNA was prepared from mouse EHS tumor, differentiated F9
teratocarcinoma cells and human hepatoma cells (Hep G2, provided by
B.B.Knowles and D.P.Alden, The Wistar Institute) using guanidine
thiocyanate extraction and CsCl centrifugation (Chirgwin et al., 1979). The
F9 cells were induced to differentiate by retinoic acid and cAMP as
previously described (Sasaki et al., 1987). Poly(A)+ RNA was selected
on an oligo(dT)-cellulose column. Three Xgtll cDNA libraries were
prepared from EHS tumor or F9 cell poly(A) + RNA using either
oligo(dT)12-18 or mixed hexanucleotides (Pharmacia, Piscataway, NJ) as
primers by standard procedures (Gubler and Hoffman, 1983; Huynh et al.
1985). An additional cDNA library in the XZAP vector (Stratagene, La
Jolla, CA) was prepared from EHS tumor poly(A)+ RNA as described
above except that EcoRI methylase was used to protect the EcoRI sites in
the cDNA.
Two expression libraries prepared in the Xgt 11 vector from mouse EHS
tumor mRNA were screened with rabbit antisera against mouse nidogen
or nidogen fragments (Paulsson et al., 1986) following established procedures
(Young and Davies, 1983; Chu et al., 1987). Four clones (insert size
0.5-1.5 kb) were eventually obtained from 2 x 106 plaques, were plaque-
purified and shown by sequence analysis to correspond to nidogen. The
largest insert was 32P-labelled by nick-translation (Rigby et al., 1977), and
used as a probe to screen the cDNA libraries from F9 mRNA (1 x 106
plaques) and from EHS tumor mRNA in XZAP (5 x 105 plaques from
unamplified library) as described (Benton and Davis, 1977). Inserts from
Xgtl 1 libraries were isolated from agarose gels (Vogelstein and Gillespie,
1979) and subcloned into the EcoRI site of the Bluescript plasmid (Stratagene,
La Jolla, CA). Clones from the XZAP library were infected with single-
stranded helper phage R408 to convert the clones from phage vector to
Bluescript vector according to the protocol provided by Stratagene.
Poly(A)+ RNA was electrophoresed on a 1% agarose gel containing 6%
formaldehyde, transferred to nitrocellulose (Thomas, 1980), and probed
with inserts from positive clones. The RNA filters were hybridized and
washed as previously described (Chu et al., 1987).
Nucleotide sequencing
Positive inserts in Bluescript plasmids were initially sequenced from both
5' and 3' directions by dideoxy chain termination sequencing of double-
stranded DNA (Chen and Seeburg, 1985), using several primers flanking
the cloning sites for the vector (Stratagene, La Jolla, CA). To determine
the complete nucleotide sequence of the cDNA, the inserts were subcloned
into various restriction sites of the M13 vector and single-stranded DNA
templates were sequenced by use of M13 universal primers or specific
primers synthesized based on available cDNA sequences. The region covered
by clone 6c was determined on average five times using the shotgun
sequencing strategy (Staden, 1982; Deininger, 1983). Most sequencing was
performed with modified T7 polymerase (Sequenase, USB, Cleveland, OH)
in dideoxy sequencing reaction mixtures containing (ca-S)thio-dATP (New
England Nuclear, Boston, MA), following the Sequenase kit manual (USB).
Some sequences were determined with four fluorescent M13 primers
following sequencing reaction conditions using Sequenase as suggested by
Applied Biosystems (Foster City, CA). Nonradioactive samples were
analyzed using an automated DNA sequencer (Applied Biosystems, Model
370A).
Cell attachment assays
Tissue culture plastic multiwell plates (Costar, Cambridge, MA) were coated
overnight at 4°C (Aumailley et al., 1987) with either the laminin-nidogen
complex, nidogen separated from the complex by dissociation with 2 M
guanidine-HCI (Paulsson et al., 1987) or with nidogen fragments.
Attachment assays were then carried out with cell suspensions in serum-
free medium for 3 h in the presence of cycloheximide (25 Ag/ml) in a
humified incubator at 370C (Aumailley and Timpl, 1986). Attached cells
were analyzed after staining with 0.1% crystal violet (Gillies et al., 1986)
inan ELISA reader (Dynatech MR 6000) at570 nm. For inhibitionassays
cell suspensions weremixed with synthetic peptides dissolved in culture
medium at different concentrations prior to the addition to the wells. Peptides
were purchased from Promega, Switzerland, and Peninsula, St Helens.
Acknowledgements
We thank Mrs Vera van Delden, Hildegard Reiter and Loretta Renkart for
skilled technical assistance. The study was supported by grants of the Fritz
Thyssen Stiftung, Deutsche Forschungsgemeinschaft and NIH AR-38912,
AR-38923 and AR-38188.
References
Appella,E., Weber,I.T. and Blasi,F. (1988) FEBS Lett., 231, 1-4.
Argraves,W.S., Suzuki,S., Arai,H., Thompson,K., Pierschbacher,M.D.
and Ruoslahti,E. (1987) J. Cell Biol., 105, 1183 -1190.
Aumailley,M. and Timpl,R. (1986) J. Cell Biol., 103, 1569-1575.
Aumailley,M., Nurcombe,V., Edgar,D., Paulsson,M. and Timpl,R. (1987)
J. Biol. Chem., 262, 11532-11538.
Benton,W.D. and Davis,R.W. (1977) Science, 196, 180-182.
Carlin,B., Jaffe,R., Bender,B. and Chung,A.E. (1981) J. Biol. Chem., 256,
5209-5214.
Carlin,B.E., Durkin,M.E., Bender,B., Jaffe,R. and Chung,A.E. (1983)
J. Biol. Chem., 258, 7729-7737.
Chen,E.Y. and Seeburg,P.H. (1985) DNA, 4, 165-170.
Chirgwin,J.M., Przybyla,A.E., MacDonald,R.J. and Rutter,W.J. (1979)
Biochemistry, 18, 5294-5299.
Chu,M.-L., Mann,K., Deutzmann,R., Pribula-Conway,D., Hsu-Chen.
C.-C., Bernard,M.P. and Timpl,R. (1987) Eur. J. Biochem., 168,
309-317.
Dedhar,S., Ruoslahti,E. and Pierschbacher,M.D. (1987) J. Cell Biol., 104,
585-593.
Deininger,P.G. (1983) Anal. Biochem., 129, 216-223.
Durkin,M.E., Carlin,B.E., Vergnes,J., Bartos,B., Marlie,J. and
Chung,A.E. (1987) Proc. Natl. Acad. Sci. USA, 84, 1570-1574.
Dziadek,M. and Timpl,R. (1985) Dev. Biol., 111, 372-382.
Dziadek,M., Paulsson,M. and Timpl,R. (1985a) EMBO J., 4, 2513-2518.
Dziadek,M., Paulsson,M., Deutzmann,R., Timpl,R., Weber,S. and Engel,J.
(1985b) In Shibata,S. (ed.), Basement Membranes. Elsevier, Amsterdam,
pp. 13-23.
Engel,J., Taylor,M., Paulsson,M., Sage,H. and Hogan,B.L.M. (1987)
Biochemistry, 26, 6958-6965.
Gillies,R.J., Didier,N. and Denton,M. (1986) Anal. Biochem., 159,
109-113.
Goodman,S.L., Deutzmann,R. and von der Mark,K. (1987) J. Cell Biol.,
105, 589-598.
Gubler,U. and Hoffman,B.J. (1983) Gene, 25, 263-269.
Hartl,L., Oberbaumer,I. and Deutzmann,R. (1988) Eur. J. Biochem., 173,
629-635.
Hogan,B.L.M., Taylor,A., Kurkinen,M. and Couchman,J.R. (1982) J. Cell
Biol., 95, 197-204.
Huttner,W.B. and Bauerle,P.A. (1988) Modem Cell Biol., 6, 97-140.
Huynh,T.V., Young,R.A. and Davis,R.W. (1985) In Glover,D.M. (ed.),
DNA Cloning. IRL Press, Oxford, Vol. I, pp. 49-78.
Hynes,R.O. (1987) Cell, 48, 549-554.
Kleinman,H.K., Cannon,F.B., Laurie,G.W., Hassell,J.R., Aumailley,M.,
Terranova,V.P., Martin,G.R. and Dubois-Dalcq,M. (1985) J. Cell.
Biochem., 27, 317-325.
Kozak,M. (1984) Nucleic Acids Res., 12, 3873-3893.
Kozak,M. (1987) Nucleic Acids Res., 15, 8125-8147.
Lipman,D.J. and Pearson,W.R. (1985) Science, 227, 1435-1441.
Malthiery,Y. and Lissitzky,S. (1987) Eur. J. Biochem., 165, 491-498.
Mann,K., Deutzmann,R. and Timpl,R. (1988) Eur. J. Biochem., in press.
Martin,G.R. and Timpl,R. (1987) Annu. Rev. Cell Biol., 3, 57-85.
Paulsson,M. (1988) J. Biol. Chem., 263, 5425-5430.
Paulsson,M., Dziadek,M., Suchanek,C., Huttner,W.B. and Timpl,R. (1985)
Biochem. J., 231, 571-579.
Paulsson,M., Deutzmann,R., Dziadek,M., Nowack,H., Timpl,R., Weber,S.
and Engel,J. (1986) Eur. J. Biochem., 156, 467-478.
Paulsson,M., Aumailley,M., Deutzmann,R., Timpl,R., Beck,K. and
Engel,J. (1987) Eur. J. Biochem., 166, 11-19.
Pytela,R., Pierschbacher,M.D. and Ruoslahti,E. (1985) Cell, 40, 191-198.
Pytela,R., Pierschbacher,M.D., Ginsberg,M.H., Plow,E.F. and
Ruoslahti,E. (1986) Science, 231, 1559-1562.
Rees,D.J.G., Jones,I.M., Handford,P.A., Walter,S.J., Esnouf,M.P.,
Smith,K.J. and Brownlee,G.G. (1988) EMBO J., 7, 2053-2061.
Rigby,P.W.I., Dieckmann,M., Rhodes,C. and Berg,P. (1977)J. Mol.Biol.,
113, 237-251.
Ruoslahti,E. (1988) Annu. Rev. Biochem., 57, 375-413.
Sasaki,M. and Yamada,Y. (1987) J. Biol. Chem., 262, 17111-17117.
71
K.Mann et al.
Sasaki,M., Kato,S., Kohno,K., Martin,G.R. and Yamada,Y. (1987) Proc.
Natl. Acad. Sci. USA, 84, 935-939.
Scott,J., Urdea,M., Quiroga,M., Sanchez-Pescador,R., Fong,N., Selby,M.,
Rutter,W.J. and Bell,G.I. (1983) Science, 221, 236-240.
Staden,R. (1982) Nucleic Acids Res., 10, 2951-2961.
Swimmer,C. and Shenk,T.C. (1984) Nucleic Acids Res., 13, 8053 -8063.
Thomas,P.S. (1980) Proc. Natl. Acad. Sci. USA, 77, 5201-5206.
Timpl,R. and Dziadek,M. (1986) Int. Rev. Exp. Pathol., 29, 1-112.
Vogelstein,B. and Gillespie,D. (1979) Proc. Natl. Acad. Sci. USA, 76,
615-619.
von Heijne,G. (1986) Nucleic Acids Res., 14, 4683-4690.
Yamada,K.M. and Kennedy,D.W. (1987) J. Cell Physiol., 130, 21-28.
Yamamoto,T., Davis,C.G., Brown,M.S., Schneider,W.J., Casey,M.L.,
Goldstein,J.L. and Russell,D.W. (1984) Cell, 39, 27-38.
Young,R.A. and Davis,R.W. (1983) Proc. Natl. Acad. Sci. USA, 80,
1194-1198.
Received on September 26, 1988
72
